Recent Trends in Seroprevalence of Celiac Disease at a Tertiary Care Center.

J Pharm Bioallied Sci

Department of Orthodontics, PGIDS, Rohtak, Haryana, India.

Published: July 2024

It is a retrospective study and all samples received in the laboratory from symptomatic patients for estimation of Immunoglobulin A (IgA) antitissue transglutaminase (IgA anti-tTGA) antibodies are included. Seroprevalence of celiac disease was determined using indirect enzyme-linked immunosorbent assay for IgA anti-tTGA. Out of 8787 serum samples received in the laboratory over a period of four years, the seroprevalence of CD was 2.1, 1.62, 0.72, and 3.3%, respectively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11426858PMC
http://dx.doi.org/10.4103/jpbs.jpbs_5_24DOI Listing

Publication Analysis

Top Keywords

seroprevalence celiac
8
celiac disease
8
samples received
8
received laboratory
8
iga anti-ttga
8
trends seroprevalence
4
disease tertiary
4
tertiary care
4
care center
4
center retrospective
4

Similar Publications

Global Prevalence and Clinical Manifestations of Celiac Disease Among First-Degree Relatives: A Systematic Review and Meta-Analysis.

Am J Gastroenterol

November 2024

Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Article Synopsis
  • First-degree relatives (FDRs) of celiac disease (CeD) patients are at a higher risk of developing the condition, with a systematic review analyzing the prevalence and symptoms using the anti-tissue transglutaminase antibody test.
  • From 34 studies involving over 10,000 FDRs, the research found a seroprevalence of 11% and a biopsy-confirmed prevalence of 7%, with daughters and sisters showing the highest rates.
  • The study suggests that about 1 in 14 FDRs may have CeD, emphasizing the need for routine screening to aid in early detection and management of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Nutritional anemia affects around 1.6 billion people globally, with limited data on its connection to celiac disease (CeD) in Western India.
  • In a study of 116 patients with nutritional anemia, 16.3% tested positive for IgA anti-tissue transglutaminase antibodies, and 9.3% had biopsy-confirmed CeD.
  • Chronic diarrhea and short stature were significant predictors of CeD, suggesting the need for routine screening of nutritional anemia patients for CeD, particularly those who don’t respond to iron treatment.
View Article and Find Full Text PDF

Meta-Analysis: Global Prevalence of Coeliac Disease in Type 1 Diabetes.

Aliment Pharmacol Ther

January 2025

Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Background: Coeliac disease (CD) is common in patients with type 1 diabetes (T1D), but prevalence varies globally due to differing screening protocols. There have been substantial changes in screening guidelines over the past two decades.

Aim: To evaluate CD prevalence in patients with T1D, focusing on screening studies using antitissue transglutaminase (anti-tTG) antibody.

View Article and Find Full Text PDF

Recent Trends in Seroprevalence of Celiac Disease at a Tertiary Care Center.

J Pharm Bioallied Sci

July 2024

Department of Orthodontics, PGIDS, Rohtak, Haryana, India.

It is a retrospective study and all samples received in the laboratory from symptomatic patients for estimation of Immunoglobulin A (IgA) antitissue transglutaminase (IgA anti-tTGA) antibodies are included. Seroprevalence of celiac disease was determined using indirect enzyme-linked immunosorbent assay for IgA anti-tTGA. Out of 8787 serum samples received in the laboratory over a period of four years, the seroprevalence of CD was 2.

View Article and Find Full Text PDF

Background: Celiac disease (CeD) is an immune-mediated disorder affecting the small bowel, associated with genetic factors and increasing global prevalence.

Aim: This study explores the association between CeD, Systemic Lupus Erythematosus (SLE), primary Sjogren syndrome (pSS), and Systemic Sclerosis (SSc).

Methods: A systematic review and meta-analysis were conducted following PRISMA guidelines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!